1108572

Astellas Pharma US Inc. — FEI 1000036852

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 4, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Northbrook, IL (United States)

Additional Details

Bioanalytical BA/BE